Biggest News Aggregation in the World
📰 Valuating News

Page 16 - Valuating News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Valuating. Real-time updates on events, politics, business and more.

Celltrion Healthcare: Celltrion Submits Investigational New Drug (IND) Application to Initiate a Global Phase III Clinical Trial Evaluating an Inhaled COVID-19 Antibody Cocktail Therapy

Celltrion submitted an IND application for a global Phase III clinical trial of inhaled antibody cocktail therapy with CT-P59 and CT-P63; the company expects to enrol 2,200 patients with mild-to-moderate
Kostenloser Wertpapierhandel Celltrion Inhalon Donna Curran Inhalon Biopharma European Medicines Agency Celltrion Group

Khondrion completes enrolment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders

Khondrion completes enrolment in KHENERGYZE Phase IIb trial evaluating sonlicromanol in adult patients with MELAS spectrum disorders NIJMEGEN, the Netherlands - 10 January 2022:
David Daley Jan Smeitink Kostenloser Wertpapierhandel Melissa Gardiner Mary Jane Elliott Consilium Strategic Communications

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating JZP150 for Once-Daily Treatment of Adults with Post-Traumatic Stress Disorder

U.S. FDA granted JZP150 Fast Track designation in PTSD, underscoring the unmet needs of patients If approved, JZP150 would become the first new drug approved in 20 years for patients
New York United States Johnh Krystal Kristin Bhavnani Andrean Flynn Rob Iannone

Bellerophon Therapeutics, Inc. Reports Positive Top-Line Data from Phase 2 Acute Dose Escalation Study of Inopulse® for Treatment of Pulmonary Hypertension Associated with Sarcoidosis

Bellerophon Therapeutics, Inc. announced positive top-line data from a recently completed Phase 2 dose escalation study evaluating the acute hemodynamic benefit of INOpulse® via right heart... | December 19, 2021
Bellerophon Therapeutics Inc Bellerophon Therapeutics Nc Stock Exchange Press Release Ight Blph Us0787713009

Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor

DUBLIN, Dec. 15, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the first patient has been enrolled in a global Phase 2b clinical trial evaluating the safety
United States United Kingdom Marka Goldstein Kristin Bhavnani Patrick Mccartney Andrean Flynn

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science